Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of February 28, 2026, Zai Lab Limited (ZLAB) has a Wall Street consensus price target of $35.00, based on estimates from 11 covering analysts. With the stock currently trading at $19.22, this represents a potential upside of +82.1%. The company has a market capitalization of $21.26B.
Analyst price targets range from a low of $35.00 to a high of $35.00, representing a 0% spread in expectations. The median target of $35.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 9 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ZLAB trades at a trailing P/E of -12.0x. Analysts expect EPS to grow +8.5% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how ZLAB stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for ZLAB is $35, representing 82.1% upside from the current price of $19.22. With 11 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
ZLAB has a consensus rating of "Buy" based on 11 Wall Street analysts. The rating breakdown is predominantly bullish, with 9 Buy/Strong Buy ratings. The consensus 12-month price target of $35 implies 82.1% upside from current levels.
ZLAB's current price is $19.22 with a consensus target of $35 (82.1% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $35 for ZLAB, while the most conservative target is $35. The consensus of $35 represents the median expectation. These targets typically reflect 12-month expectations.
ZLAB is moderately covered, with 11 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 9 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ZLAB stock forecast based on 11 Wall Street analysts shows a consensus price target of $35, with estimates ranging from $35 (bear case) to $35 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on ZLAB, with a "Buy" consensus rating and $35 price target (82.1% upside). 9 of 11 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ZLAB analyst price targets range from $35 to $35, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $35 consensus represents the middle ground.